Octreotide Acetate Injection
制剂 FDF · Injection · (1)1 ml:0.05 mg (2)1ml:0.1mg (3)1ml:0.3mg
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Octreotide Acetate Injection
- Dosage Form
- Injection
- Strength
- (1)1 ml:0.05 mg (2)1ml:0.1mg (3)1ml:0.3mg
- Therapy Area
- Metabolic & Endocrinology
- Indication
- Acromegaly; Gastroenteropancreatic neuroendocrine tumour; Prophylaxis of complications after pancreatic surgery; Gastrooesophageal variceal haemorrhage
- Current Status
- 官方 FDF 授权目录（UB504）
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —